| Date Filed | Type | Description |
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/28/2019 |
4
| KAZANCHYAN ANNA (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Sold 7,049 shares
@ $3.27, valued at
$23.1k
|
|
| 07/17/2019 |
4
| KAZANCHYAN ANNA (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Sold 808 shares
@ $2.31, valued at
$1.9k
|
|
| 05/20/2019 |
4
| KAZANCHYAN ANNA (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 28,195 shares
@ $0
Sold 10,600 shares
@ $2.61, valued at
$27.7k
|
|
| 05/10/2018 |
4
| KAZANCHYAN ANNA (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 14,829 shares
@ $0 |
|
| 02/08/2018 |
3
| KAZANCHYAN ANNA (Director) has filed a Form 3 on INNOVATE BIOPHARMACEUTICALS, INC. |
| 01/11/2018 |
3
| KAZANCHYAN ANNA (Director) has filed a Form 3 on Foamix Pharmaceuticals Ltd. |
| 11/16/2007 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/16/2007 |
4
| KAZANCHYAN ANNA (See Remarks) has filed a Form 4 on NAREK PHARMACEUTICALS|
Txns:
| Disposed of 14,000,000 shares
@ $0.0036, valued at
$50.4k
|
|
| 11/16/2007 |
4
| KAZANCHYAN ANNA (See Remarks) has filed a Form 4 on HERATSI PHARMACEUTICALS|
Txns:
| Disposed of 14,000,000 shares
@ $0.0036, valued at
$50.4k
|
|
| 11/16/2007 |
SC 13D/A
|
SEC Filing in the EDGAR database
|
| 07/27/2006 |
SC 13D
| KAZANCHYAN ANNA reports a 0% stake in |
| 07/27/2006 |
SC 13D
| KAZANCHYAN ANNA reports a 0% stake in |